1. Ultrasmall Copper (I) Sulfide Nanoparticles Prevent Hepatitis B Virus Infection. Guo, X., M.Z. Sun, R. Gao, A.H. Qu, C. Chen, C.L. Xu, H. Kuang, and L.G. Xu. Angewandte Chemie, 2021. 60(23): p. 13073-13080. ISI[000648084300001].
[WOS]. HBV_05_2021.
2. Identification of a Novel Long-acting 4'-Modified Nucleoside Reverse Transcriptase Inhibitor against HBV.Higashi-Kuwata, N., S. Hayashi, H. Kumamoto, H. Ogata-Aoki, D. Das, D. Venzon, S.I. Hattori, H. Bulut, M. Hashimoto, M. Otagiri, N. Takamune, N. Kishimoto, D.A. Davis, S. Misumi, M. Kakuni, Y. Tanaka, and H. Mitsuya. Journal of Hepatology, 2021. 74(5): p. 1075-1086. PMID[33333207].
[PubMed]. HBV_05_2021.
3. Discovery of Novel Pyrimidine-based Capsid Assembly Modulators as Potent anti-HBV Agents. Kim, W., J.A. Kang, M. Park, P.H. Jeong, Y.J. Kim, Y. Cho, S.G. Park, and Y.C. Kim. Journal of Medicinal Chemistry, 2021. 64(9): p. 5500-5518. PMID[33887912].
[PubMed]. HBV_05_2021.
4. Identification of a New Class of HBV Capsid Assembly Modulator. Kuduk, S.D., B. Stoops, R. Alexander, A.M. Lam, C. Espiritu, R. Vogel, V. Lau, K. Klumpp, O.A. Flores, and G.D. Hartman. Bioorganic & Medicinal Chemistry Letters, 2021. 39: 127848. PMID[33610748].
[PubMed]. HBV_05_2021.
5. Introduction of a Cyano Group at the 2-Position of an (R,S)-3-Hydroxy-2-(phosphonomethoxy)propyl (HPMP) Derivative of Thymine Elicits Selective anti-HBV Activity. Tan, S., E. Groaz, M.N. Prichard, R. Kalkeri, R. Ptak, and P. Herdewijn. RSC Medicinal Chemistry, 2021. 12. ISI[000645224600001].
[WOS]. HBV_05_2021.
Patent Citations
6. Substituted Isoindolonyl 2,2'-Bipyrimidinyl Compounds, Analogues Thereof, and Methods Using Same.Chen, S., A.G. Cole, B.D. Dorsey, B.J. Dugan, Y. Fan, D.B. Gotchev, R. Kakarla, J. Quintero, and M.J. Sofia. Patent. 2021. 2020-US60203 2021097075: 163pp.
[Patent]. HBV_05_2021.